The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study
Open accessAbstract
Objective: To clarify the temporal relationship between systemic inflammation and neurodegeneration, we examined whether a higher level of circulating inflammatory markers during midlife was associated with smaller brain volumes in late life using a large biracial prospective cohort study. Methods: Plasma levels of systemic inflammatory markers (fibrinogen, albumin, white blood cell count, von Willebrand factor, and Factor VIII) were assessed at baseline in 1,633 participants (mean age 53 [5] years, 60% female, 27% African American) enrolled in the Atherosclerosis Risk in Communities Study. Using all 5 inflammatory markers, an inflammation composite score was created for each participant. We assessed episodic memory and regional brain volumes, using 3T MRI, 24 years later. Results: Each SD increase in midlife inflammation composite score was associated with 1,788 mm3 greater ventricular (p = 0.013), 110 mm3 smaller hippocampal (p = 0.013), 519 mm3 smaller occipital (p = 0.009), and 532 mm3 smaller Alzheimer disease signature region (p = 0.008) volumes, and reduced episodic memory (p = 0.046) 24 years later. Compared to participants with no elevated (4th quartile) midlife inflammatory markers, participants with elevations in 3 or more markers had, on average, 5% smaller hippocampal and Alzheimer disease signature region volumes. The association between midlife inflammation and late-life brain volume was modified by age and race, whereby younger participants and white participants with higher levels of systemic inflammation during midlife were more likely to show reduced brain volumes subsequently. Conclusions: Our prospective findings provide evidence for what may be an early contributory role of systemic inflammation in neurodegeneration and cognitive aging.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, elevations in inflammatory proteins during midlife have been associated with smaller brain volumes and abnormal white matter microstructural integrity 20+ years later, during late-life.93”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [93]
Citations
Cites
Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Inflammatory markers and the risk of Alzheimer disease: The Framingham Study
Tan, Z. S., Beiser, A. S., Vasan, R. S., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Au, R., Kiel, D. P., Wolf, P. A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000263217.36439.da · Cited by 440
Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice
Krstic, D., Madhusudan, A., Doehner, J., Vogel, P., Notter, T., Imhof, C., Manalastas, A., Hilfiker, M., Pfister, S., Schwerdel, C., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-151 · Cited by 400
Risk of Dementia Among White and African American Relatives of Patients With Alzheimer Disease
Green, R. C. (2002) · JAMA · doi:10.1001/jama.287.3.329 · Cited by 391
Microglial immunophenotype in dementia with Alzheimer’s pathology
CFAS, M., Minett, T., Classey, J., Matthews, F. E., Fahrenhold, M., Taga, M., Brayne, C., Ince, P. G., Nicoll, J. A. R., & Boche, D. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0601-z · Cited by 219
Research works printed but not linked: 33
- 10.1002/ana.10414 · DOI
- 10.1016/j.neurobiolaging.2015.10.008 · DOI · Paper page
- 10.1212/01.wnl.0000257815.20548.df · DOI
- 10.1212/WNL.0b013e3181d7b45b · DOI
- 10.1016/j.bbi.2011.07.240 · DOI
- 10.1111/jgs.14283 · DOI
- 10.1212/WNL.0b013e318248e50f · DOI
- 10.1093/oxfordjournals.aje.a115184 · DOI
- 10.1161/STROKEAHA.114.007847 · DOI
- 10.1055/s-0038-1646519 · DOI
- 10.1161/01.CIR.96.4.1102 · DOI
- 10.1016/1047-2797(92)90017-K · DOI
- Eckfeldt JH, Chambless LE, Shen YL. Short-term, within-person variability in clinical chemistry test results: experience from the Atherosclerosis Risk in Communities Study. Arch Pathol Lab Med 1994;118:496–500.
- 10.1212/WNL.0b013e3182166e96 · DOI
- 10.1097/WAD.0000000000000042 · DOI
- 10.1016/j.dadm.2015.12.002 · DOI
- 10.1515/cclm.1984.22.2.165 · DOI
- 10.1093/clinchem/29.6.1075 · DOI
- 10.1093/clinchem/36.1.36 · DOI
- 10.1016/S1053-8119(02)00026-5 · DOI
- 10.1001/jamaneurol.2014.1646 · DOI · Paper page
- 10.1212/WNL.56.12.1683 · DOI · Paper page
- 10.7326/M14-0737 · DOI · Paper page
- 10.1038/nrneurol.2012.236 · DOI · Paper page
- 10.1161/01.CIR.0000158136.76824.04 · DOI · Paper page
- 10.1016/j.expneurol.2010.11.014 · DOI · Paper page
- 10.1111/j.1750-3639.1998.tb00189.x · DOI · Paper page
- 10.1093/bja/aep037 · DOI
- 10.1016/j.biopsych.2012.04.002 · DOI
- 10.1523/JNEUROSCI.2614-05.2005 · DOI · Paper page
- 10.1186/1742-2094-5-25 · DOI
- 10.1093/aje/kwu020 · DOI
- 10.1002/hbm.21334 · DOI
Cited by
Sorted by citations
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
“Similarly, elevations in inflammatory proteins during midlife have been associated with smaller brain volumes and abnormal white matter microstructural integrity 20+ years later, during late-life.(93) Fig.”
BackgroundInflammation: the link between comorbidities, genetics, and Alzheimer’s disease
Newcombe, E. A., Camats-Perna, J., Silva, M. L., Valmas, N., Huat, T. J., & Medeiros, R. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1313-3 · Cited by 532
Systemic inflammation during midlife and cognitive change over 20 years: The ARIC Study
Walker, K. A., Gottesman, R. F., Wu, A., Knopman, D. S., Gross, A. L., Mosley, T. H., Selvin, E., & Windham, B. G. (2019) · Neurology · doi:10.1212/wnl.0000000000007094 · Cited by 282
Self-citationUnderstanding the Role of Systemic Inflammation in Alzheimer’s Disease
Walker, K. A., Ficek, B. N., & Westbrook, R. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00333 · Cited by 259
Self-citationDiet, inflammation and the gut microbiome: mechanisms for obesity-associated cognitive impairment
Leigh, S.-J., & Morris, M. J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165767 · Cited by 221
Peripheral immune system in aging and Alzheimer’s disease
Cao, W., & Zheng, H. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0284-2 · Cited by 214
Muzambi, R., Bhaskaran, K., Smeeth, L., Brayne, C., Chaturvedi, N., & Warren-Gash, C. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00118-5 · Cited by 84
Inflammation and neurodegeneration: chronicity matters
Walker, K. A. (2018) · Aging · doi:10.18632/aging.101704 · Cited by 66
Self-citationSáez de Asteasu, M. L., Cuevas-Lara, C., García-Hermoso, A., Ramírez-Vélez, R., Martínez-Velilla, N., Zambom-Ferraresi, F., Cadore, E. L., & Izquierdo, M. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220103 · Cited by 28
Association of hospitalization, critical illness, and infection with brain structure in older adults
Walker, K. A., Gottesman, R. F., Wu, A., Knopman, D. S., Mosley, T. H., Alonso, A., Kucharska‐Newton, A., & Brown, C. H. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15470 · Cited by 20
Self-citationEstablishing the relationship between brain cellular senescence and brain structure
Lund, A. N., Kopell, B. H., Golestani, N., Vornholt, E., Thompson, R. C., Liharska, L. E., Luo, Y., Cheng, E., Park, Y. J., Fennessy, B., et al. (2026) · Cell · doi:10.1016/j.cell.2025.10.014 · Cited by 6
Metadata
- Authors
- Walker, K. A., Hoogeveen, R. C., Folsom, A. R., Ballantyne, C. M., Knopman, D. S., Windham, B. G., Jack, C. R., & Gottesman, R. F.
- Affiliations
- Houston Methodist (US)
- ORCID
- Venue
- Neurology
- Published
- 2017-11-28
- Volume
- 89
- Issue
- 22
- Pages
- 2262-2270
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC5705246
- OpenAlex
- W2767064326
- Cited by
- 150
- References
- 6
- Citations by year
- 2026: 20 · 2025: 14 · 2024: 22 · 2023: 19 · 2022: 13 · 2021: 10 · 2020: 15 · 2019: 15 · 2018: 22
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Update notices
- correction (2023-08-21)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u01hl096899-08, 5u01hl096902-08)
- National Institute on Aging (K24AG052573, T32AG027668)
- National Heart, Lung, and Blood Institute (U01HL096814, U01-HL-096899, U01-HL-096902, U01HL096917, U01HL096812)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- systemic inflammation, brain volume, hippocampal volume, ventriculomegaly, episodic memory, neurodegeneration, cognitive aging, fibrinogen, von Willebrand factor, factor VIII, white blood cell count, albumin, racial differences, age differences
- MeSH terms
- Age Factors, Aged, Black or African American, Brain, Factor VIII, Female, Fibrinogen, Humans, Inflammation, Leukocyte Count, Magnetic Resonance Imaging, Male, Middle Aged, Prospective Studies, Residence Characteristics, Risk Factors, Sex Factors, von Willebrand Factor, Neurodegenerative Diseases, White People, Atherosclerosis, Memory, Episodic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review